Research ExplorerScientific StaffRadwan Massoud Publications

Dr. ID: 10951663

Radwan Massoud

graph of relations
Affiliations
1 - 11 out of 11Page size: 50

Publications

  1. 2024

  2. Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR

    Klyuchnikov, E., Badbaran, A., Massoud, R., Freiberger, P., Wolschke, C., Ayuk, F., Fehse, B., Bacher, U. & Kröger, N., 02.2024, In: LEUKEMIA. 38, 2, p. 386-388 3 p.

    Research output: SCORING: Contribution to journal › Letter › Research › peer-review

  3. Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation

    Weise, G., Massoud, R., Krause, R., Heidenreich, S., Janson, D., Klyuchnikov, E., Wolschke, C., Zeck, G., Kröger, N. & Ayuk, F., 25.01.2024, In: CANCERS. 16, 3, 515.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. 2023

  5. Spleen volume and length determined by computed tomography impact outcome after allogeneic stem cell transplantation for myelofibrosis

    Luther, M., Henes, F. O., Zabelina, T., Massoud, R., Janson, D., Wolschke, C., Klyuchnikov, E., Gagelmann, N., Fehse, B., Adam, G., Kröger, N. & Ayuk, F., 07.2023, In: BONE MARROW TRANSPL. 58, 7, p. 755-761 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Individualized busulfan dosing improves outcomes compared to fixed-dose administration in pre-transplant minimal residual disease-positive acute myeloid leukemia patients with intermediate-risk undergoing allogeneic stem cell transplantation in CR

    Klyuchnikov, E., Langebrake, C., Badbaran, A., Dadkhah, A., Massoud, R., Freiberger, P., Ayuk, F., Janson, D., Wolschke, C., Bacher, U. & Kröger, N., 02.2023, In: EUR J HAEMATOL. 110, 2, p. 188-197 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 2022

  8. Impact of Anti-T-lymphocyte globulin dosing on GVHD and Immune reconstitution in matched unrelated myeloablative peripheral blood stem cell transplantation

    Massoud, R., Klyuchnikov, E., Gagelmann, N., Zabelina, T., Wolschke, C., Ayuk, F., Fritzsche-Friedland, U., Zander, A. & Kröger, N., 10.2022, In: BONE MARROW TRANSPL. 57, 10, p. 1548-1555 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

    Gagelmann, N., Passamonti, F., Wolschke, C., Massoud, R., Niederwieser, C., Adjallé, R., Mora, B., Ayuk, F. & Kröger, N., 01.08.2022, In: HAEMATOLOGICA. 107, 8, p. 1840-1849 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission

    Klyuchnikov, E., Badbaran, A., Massoud, R., Fritzsche-Friedland, U., Freiberger, P., Ayuk, F., Wolschke, C., Bacher, U. & Kröger, N., 07.2022, In: TRANSPL CELL THER. 28, 7, p. 374.e1-374.e9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Post-Transplantation Multicolored Flow Cytometry-Minimal Residual Disease Status on Day 100 Predicts Outcomes for Patients With Refractory Acute Myeloid Leukemia

    Klyuchnikov, E., Badbaran, A., Massoud, R., Fritsche-Friedland, U., Janson, D., Ayuk, F., Christopeit, M., Wolschke, C., Bacher, U. & Kröger, N., 05.2022, In: TRANSPL CELL THER. 28, 5, p. 267.e1-267.e7

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Comparison of immune reconstitution between anti-T-lymphocyte globulin and post-transplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation

    Massoud, R., Gagelmann, N., Fritzsche-Friedland, U., Zeck, G., Heidenreich, S., Wolschke, C., Ayuk, F., Christopeit, M. & Kröger, N., 01.04.2022, In: HAEMATOLOGICA. 107, 4, p. 857-867 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 2021

  14. Enhanced Immune Reconstitution of γδ T Cells after Allogeneic Stem Cell Transplantation Overcomes the Negative Impact of Pretransplantation Minimal Residual Disease-Positive Status in Patients with Acute Myelogenous Leukemia

    Klyuchnikov, E., Badbaran, A., Massoud, R., Fritsche-Friedland, U., Janson, D., Ayuk, F., Wolschke, C., Bacher, U. & Kröger, N., 10.2021, In: TRANSPL CELL THER. 27, 10, p. 841-850 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection

    Christopeit, M., Reichard, M., Niederwieser, C., Massoud, R., Klyuchnikov, E., Haase, N., Wolschke, C., Ayuk, F., Heidenreich, S. & Kröger, N., 06.2021, In: BONE MARROW TRANSPL. 56, 6, p. 1478-1481 4 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research